ctce-9908 and Ovarian-Neoplasms

The chemokine receptor CXCR4 is expressed by malignant cells in ovarian cancer and is implicated in their growth and spread. We report here a unique mechanism of action of a small peptide antagonist of CXCR4 on ovarian cancer cells: induction of cell death by mitotic catastrophe. CTCE-9908 inhibited ovarian cancer cell migration to CXCL12, but on longer incubation, caused cell death in CXCR4-positive cells. CTCE-9908 did not cause apoptosis or cellular senescence, but induced multinucleation, G(2)-M arrest, and abnormal mitosis in ovarian cancer cells. This suggests that cell death was caused by mitotic catastrophe. Using microarray and Western blot analysis, we showed that CTCE-9908 deregulated DNA damage checkpoint proteins and spindle assembly checkpoint proteins at G(2)-M phases of the cell cycle. Combination treatment of CTCE-9908 and the drug paclitaxel led to an additive cytotoxicity that also involved mitotic catastrophe. We conclude that CTCE-9908 has a unique mechanism of action in ovarian cancer cells that seems to be CXCR4 specific.

Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Division; Cell Movement; Cell Nucleus; Cell Proliferation; Cellular Senescence; DNA Damage; DNA Replication; Drug Therapy, Combination; Female; Flow Cytometry; G2 Phase; Humans; Mitosis; Ovarian Neoplasms; Paclitaxel; Peptides; Receptors, CXCR4; Tumor Cells, Cultured